Sam and Jeff discuss the ethical question of whether there should be a market in vaccine privileges during the tail end of the COVID pandemic. They explore the potential benefits and harms of such a market, drawing parallels to debates on the sale of organs for transplantation and the distribution of medical resources in society.
